These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 18641236)

  • 1. Pulmonary applications and toxicity of engineered nanoparticles.
    Card JW; Zeldin DC; Bonner JC; Nestmann ER
    Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L400-11. PubMed ID: 18641236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles as a potential cause of pleural and interstitial lung disease.
    Bonner JC
    Proc Am Thorac Soc; 2010 May; 7(2):138-41. PubMed ID: 20427587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?
    Joshi N
    Ther Deliv; 2018 Mar; 9(4):233-236. PubMed ID: 29495926
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicological aspects and applications of nanoparticles in paediatric respiratory disease.
    Dobson J
    Paediatr Respir Rev; 2007 Mar; 8(1):62-6. PubMed ID: 17419979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery and nanoparticles:applications and hazards.
    De Jong WH; Borm PJ
    Int J Nanomedicine; 2008; 3(2):133-49. PubMed ID: 18686775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles: a review of particle toxicology following inhalation exposure.
    Bakand S; Hayes A; Dechsakulthorn F
    Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the effects of manufactured nanoparticles on mammalian target organs.
    Wu T; Tang M
    J Appl Toxicol; 2018 Jan; 38(1):25-40. PubMed ID: 28799656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in pulmonary delivery of nanoparticles.
    Kaur G; Narang RK; Rath G; Goyal AK
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):75-96. PubMed ID: 21806501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers.
    Simeonova PP; Erdely A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():68-73. PubMed ID: 19558236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Nanoparticles and Their Targeted Delivery Applications.
    Yetisgin AA; Cetinel S; Zuvin M; Kosar A; Kutlu O
    Molecules; 2020 May; 25(9):. PubMed ID: 32397080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles.
    Garcia-Mouton C; Hidalgo A; Cruz A; Pérez-Gil J
    Eur J Pharm Biopharm; 2019 Nov; 144():230-243. PubMed ID: 31560956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological assessment of nanoparticle interactions with the pulmonary system.
    Osman NM; Sexton DW; Saleem IY
    Nanotoxicology; 2020 Feb; 14(1):21-58. PubMed ID: 31502904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles, nanotechnology and pulmonary nanotoxicology.
    Ferreira AJ; Cemlyn-Jones J; Robalo Cordeiro C
    Rev Port Pneumol; 2013; 19(1):28-37. PubMed ID: 23265236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles in medicine: therapeutic applications and developments.
    Zhang L; Gu FX; Chan JM; Wang AZ; Langer RS; Farokhzad OC
    Clin Pharmacol Ther; 2008 May; 83(5):761-9. PubMed ID: 17957183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological effects of nano-sized particles on the respiratory system.
    Nho R
    Nanomedicine; 2020 Oct; 29():102242. PubMed ID: 32561255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicological perspectives of inhaled therapeutics and nanoparticles.
    Hayes AJ; Bakand S
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):933-47. PubMed ID: 24810077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology in respiratory medicine.
    Omlor AJ; Nguyen J; Bals R; Dinh QT
    Respir Res; 2015 May; 16(1):64. PubMed ID: 26021823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of current toxicological knowledge of engineered nanoparticles.
    Castranova V
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S14-7. PubMed ID: 21606847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.